Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoints Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Design Optimization of Reduced-Diameter Implants in Simulated and Cadaver Bone
Supramolecular Assemblies for Detecting Biomarkers in Complex Mixtures
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
Targeted Nanoprobes For Intraoperative optical Imaging of Breast Cancer Margins
Trapping of Catalytic Intermediates in Rubisco From C Caldarium and IN Mips Fro
Recently added grants:
s100a4 Signaling in Fibrotic Diabetic Tendon Healing
Macrophage phenotype orchestrates mammalian tissue regeneration
Defining the Human Articular Chondrocyte Lineage
Predictors of Myelodysplastic Syndrome in Minnesota
Metabolic Reprogramming in Brain Tumors
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN53301-4-0-1
Application #
7587158
Study Section
Project Start
2005-08-30
Project End
2009-08-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/ Ohio State University
$1,487,781
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Pereira, Michael /
$1,397,602
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoints Assays
/
Comments
Be the first to comment on this grant